5-Iodo-1H-indazol-3-amine(CAS: 88805-76-9)

5-Iodo-1H-indazol-3-amine (CAS: 88805-76-9) falls under the classification of organic compounds and is subject to the Global Harmonized System (GHS) for classification and labeling of chemicals. For manufacturing and import/export, it is also regulated by REACH in the European Union, which requires registration and authorization for certain substances. In the U.S., the FDA may regulate its use in pharmaceuticals, and the EPA oversees its use and disposal in environmental contexts.

While 5-Iodo-1H-indazol-3-amine is a specific compound, there are similar indazoles such as 5-chloro-1H-indazol-3-amine and 5-bromo-1H-indazol-3-amine that can be used as alternatives. Other synthetic methods like using different functional groups or other nitrogen heterocycles can also provide alternative pathways to achieve similar pharmacological properties.

The market and research trends for 5-Iodo-1H-indazol-3-amine (CAS: 88805-76-9) are primarily focused on its potential applications in medicinal chemistry and drug development. Recent research has explored its use as a potential anti-inflammatory and antiviral agent. As a result, there is growing interest in its synthesis and biological evaluation, with ongoing studies aiming to understand its mechanisms of action and explore its therapeutic potential.

Waste containing 5-Iodo-1H-indazol-3-amine (CAS: 88805-76-9) should be collected in a sealed, leak-proof container and stored in a dry, cool area away from incompatible materials. For disposal, it is recommended to consult with a hazardous waste management company for proper incineration or other professional waste disposal methods. Environmental protection measures should include ensuring no spillage or release during handling and transport to minimize environmental impact.